In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

References

• DoiYMurrayGLPelegAYAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsSemin Respir Crit Care Med2015361859825643273
   PubMed Web of Science ®Google Scholar
• ViehmanJANguyenMHDoiYTreatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsDrugs201474121315133325091170
   PubMed Web of Science ®Google Scholar
• LynchJPZhanelGGClarkNMInfections due to Acinetobacter baumannii in the ICU: treatment optionsSemin Respir Crit Care Med201738331132528578555
   PubMed Web of Science ®Google Scholar
• Garnacho-MonteroJDimopoulosGPoulakouGTask force on management and prevention of Acinetobacter baumannii infections in the ICUIntensive Care Med201541122057207526438224
   PubMed Web of Science ®Google Scholar
• VazinAKarimzadehIZandAHatami-MazinaniNFirouzabadiDEvaluating adherence of health-care team to standard guideline of colistin use at intensive care units of a referral hospital in Shiraz, Southwest of IranAdv Pharm Bull20177339139729071221
   PubMedGoogle Scholar
• OlaitanAOMorandSRolainJMMechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteriaFront Microbiol2014564325505462
   PubMed Web of Science ®Google Scholar
• BoucherHWTalbotGHBradleyJSBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaClin Infect Dis200948111219035777
   PubMed Web of Science ®Google Scholar
• TalbotGHBradleyJEdwardsJEBad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClin Infect Dis200642565766816447111
   PubMed Web of Science ®Google Scholar
• WongDNielsenTBBonomoRAPantapalangkoorPLunaBSpellbergBClinical and pathophysiological overview of acinetobacter infections: a century of challengesClin Microbiol Rev201730140944727974412
   PubMed Web of Science ®Google Scholar
• BergenPJLandersdorferCBLeeHJLiJNationRL“Old” antibiotics for emerging multidrug-resistant bacteriaCurr Opin Infect Dis201225662663323041772
   PubMed Web of Science ®Google Scholar
• AnvarinejadMJaponiADavarpanahMAMahmudiHMamminaCVazinAPhenotypic and molecular epidemiology of acinetobacter calcoaceticus baumannii complex strains spread at Nemazee Hospital of Shiraz, IranJundishapur J Microbiol201586e1918026322204
   PubMed Web of Science ®Google Scholar
• VourliSFrantzeskakiFMeletiadisJSynergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patientsInt J Antimicrob Agents201545667067125795317
   PubMed Web of Science ®Google Scholar
• ThamlikitkulVTiengrimSIn vitro activity of colistin plus sulbac-tam against extensive-drug-resistant Acinetobacter baumannii by checkerboard methodJ Med Assoc Thai201497Suppl 3S1S6
   Google Scholar
• NastroMRodríguezCHMongeRActivity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteriaJ Chemother201426421121624070502
   PubMed Web of Science ®Google Scholar
• PercinDAkyolSKalinGIn vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acineto-bacter baumanniiGMS Hyg Infect Control201492Doc1425152859
   PubMedGoogle Scholar
• VidaillacCBenichouLDuvalREIn vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolatesAntimicrob Agents Chemother20125694856486122751540
   PubMed Web of Science ®Google Scholar
• HigginsPGLehmannMWisplinghoffHSeifertHgyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3J Clin Microbiol201048124592459420881170
   PubMed Web of Science ®Google Scholar
• SchwalbeRSteele-MooreLGoodwinACAntimicrobial Susceptibility Testing ProtocolsBoca Raton, FLCRC Press2007
   Google Scholar
• PatilSVHajareALPatankarMKrishnaprasadKIn vitro fractional inhibitory concentration (FIC) study of cefixime and azithromycin fixed dose combination (FDC) against respiratory clinical isolatesJ Clin Diagn Res201592DC13DC15
   Google Scholar
• HoggGMBarrJGWebbCHIn-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumanniiJ Antimicrob Chemother19984144944959598783
   PubMed Web of Science ®Google Scholar
• MohammadiMKhayatHSayehmiriKSynergistic effect of colistin and rifampin against multidrug resistant Acinetobacter baumannii: a systematic review and meta-analysisOpen Microbiol J201711637128553417
   PubMedGoogle Scholar
• GraysonMLCroweSMMcCarthyJSKucers’ the Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs Ed USCRC Press2010
   Google Scholar
• NiWShaoXdiXCuiJWangRLiuYIn vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysisInt J Antimicrob Agents201545181825465524
   PubMed Web of Science ®Google Scholar
• ZusmanOAvniTLeiboviciLSystematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsAntimicrob Agents Chemother201357105104511123917322
   PubMed Web of Science ®Google Scholar
• CıkmanACeylanMRParlakMKarahocagilMKBerktaşMEvaluation of colistin-ampicillin/sulbactam combination efficacy in imipenem-resistant acinetobacter baumannii strainsMikrobiyol Bul201347114715123390912
   PubMed Web of Science ®Google Scholar
• WeiWYangHLiuYYeYLiJIn vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemaseJ Chemother201628315916325978105
   PubMed Web of Science ®Google Scholar
• JiangZHeXLiJSynergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysisInfect Drug Resist2018111083109530122965
   PubMed Web of Science ®Google Scholar